Clinical Trial: Long Term Prophylactic Therapy of Congenital Long QT Syndrome Type III (LQT3) With Ranolazine

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title:

Brief Summary: The purpose of this study is to determine whether ranolazine will reduce the risk of arrhythmic events in patients with long QT syndrome type 3.